Medicine and Dentistry
Adverse Event
12%
Anemia
19%
Cancer Therapy
9%
Clear Cell Renal Cell Carcinoma
28%
Clinical Trial
12%
Cohort Analysis
11%
Colorectal Carcinoma
11%
Colorectal Liver Metastasis
100%
Colorectal Tumor
10%
Cryoablation
16%
Disease
10%
Disease Free Survival
13%
Fas Ligand
19%
Hemihepatectomy
10%
Hepatectomy
23%
Hepatocellular Carcinoma
12%
Hypoxia
24%
Iron Deficiency
14%
Irreversible Electroporation
11%
Ischemia
28%
Kidney Tumour
12%
Liver Metastasis
25%
Liver Surgery
31%
Liver Transplantation
18%
Liver Tumor
10%
Machine Perfusion
18%
Malignant Neoplasm
15%
Metastatic Carcinoma
29%
Micrometastasis
25%
Necrosis
10%
Neoplasm
50%
Nutritional Support
14%
Overall Survival
28%
Pancreas Adenocarcinoma
18%
Pancreas Cancer
52%
Pancreas Fistula
11%
Pancreatic Surgery
21%
Pancreaticoduodenectomy
32%
Partial Nephrectomy
14%
Prognostic Factor
12%
Programmed Cell Death
19%
Radiofrequency Ablation
74%
Recurrent Disease
24%
Supplementation
14%
Surgery
55%
Surgery
18%
Systematic Review
19%
Tumor Cell
29%
Tumor Progression
28%
Tumor Recurrence
14%
Keyphrases
90-day Mortality
11%
Anatomic Liver Resection
10%
Cannabis Products
9%
CD95
18%
CD95L
11%
Clinical Outcomes
9%
Colorectal Liver Metastases
48%
Complication after Surgery
9%
Extended Hemihepatectomy
10%
External Validation
10%
Interleukin-2
9%
Intravenous Iron Therapy
9%
Iron Deficiency
9%
Irreversible Electroporation
11%
Long-term Survivors
9%
Micrometastasis
12%
Microwave Ablation
9%
Mouse Liver
9%
Multicenter Cohort Study
9%
Multicenter Randomized Controlled Trial
9%
Multidisciplinary Team
9%
Oncological Outcomes
11%
Overall Survival
19%
Pancreas
9%
Pancreatic Cancer
10%
Pancreatic Ductal Adenocarcinoma
18%
Pancreatic Neuroendocrine Tumors (pNETs)
9%
Pancreatic Surgery
18%
Pancreaticoduodenectomy
26%
Parallel Electrode
9%
Poor Prognostic Factors
9%
Postoperative Outcomes
10%
Prehabilitation
18%
Preoperative Anemia
11%
Prognostic Marker
9%
Radiofrequency Ablation
28%
Renal Cell Carcinoma
9%
Resectability
9%
Resectable Pancreatic Cancer
11%
Resection
19%
Risk Factors for Complications
9%
Risk Model
12%
Robotic Liver Surgery
9%
Severe Complications
14%
Surgical Outcomes
9%
Team Assessment
9%
Todani
9%
Treatment Allocation
9%
Two Parallel Plates
9%
Type 1 Diabetes Mellitus (T1DM)
9%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
7%
Cannabis
9%
CD8 Antigen
8%
Clinical Trial
12%
Colorectal Carcinoma
13%
Colorectal Liver Metastasis
46%
Colorectal Tumor
13%
Epidermal Growth Factor Receptor
9%
Fas Ligand
9%
Gallbladder Cancer
9%
Granulocyte Colony Stimulating Factor
9%
Growth Factor Receptor
9%
Hypoxia
20%
Interleukin 2
18%
Irinotecan
9%
Ischemia
14%
Liver Cancer
9%
Liver Metastasis
5%
Liver Tumor
10%
Malignant Neoplasm
18%
Metastasis
11%
Micrometastasis
17%
Necrosis
9%
Neoplasm
61%
Pancreas Cancer
11%
Porcine Model
9%
Randomized Controlled Trial
9%
Recurrent Disease
13%
Renal Cell Carcinoma
18%
Spleen Abscess
9%
Tirapazamine
9%
Tumor Growth
19%
Tumor Recurrence
9%